Back to search

Article

African Green Monkey Cerebrospinal Fluid miRNome Captures Conserved miRNAs Relevant to Human Neurodegenerative Disease

2026-08-13

Abstract excerpt

<h4>Background: </h4> The African green monkey (AGM) is increasingly used as a model for early stage Alzheimer's disease (AD), with cerebrospinal fluid (CSF) targeted for biomarker discovery and longitudinal disease monitoring of shifts in the central nervous system. MicroRNAs (miRNAs) are particularly informative indicators of early neuropathological change. Despite the complementary value of an early stage disea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dc05e98e-c937-5c40-a1ad-d2c255e1c637
DOI
10.64898/2026.08.07.743104
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
African Green Monkey Cerebrospinal Fluid miRNome Captures Conserved miRNAs Relevant to Human Neurodegenerative DiseaseDOI 10.64898/2026.08.07.743104
MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.Semantic proximity
Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer’s DiseaseSemantic proximity
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s DiseaseSemantic proximity
A super-series of extracellular miRNA in cerebrospinal fluid reveals broad patterns associated with neurologic diseaseSemantic proximity
African Green Monkeys Respond to Synthetic Aβ Oligomers with Persistent Alzheimer’s-like ActivationSemantic proximity
Transcriptome profiling of cerebrospinal fluid in Alzheimer’s Disease reveals molecular dysregulations associated with diseaseSemantic proximity
Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s diseaseSemantic proximity
A multi-omics approach identifies a blood-based miRNA signature of cognitive decline in two large observational trialsSemantic proximity
Cerebrospinal fluid CD4+ T lymphocyte-derived miRNA-let-7b can enhances the diagnostic performance of Alzheimer's disease biomarkersSemantic proximity
Validation of MicroRNA Biomarkers for Alzheimer’s Disease in Human Cerebrospinal FluidSemantic proximity
MicroRNAs in tear fluids predict underlying molecular changes associated with Alzheimer’s diseaseSemantic proximity
microRNA-based predictor for diagnosis of frontotemporal dementiaSemantic proximity
Select a neighboring publication to make it the new centre.